Crossmark

Comparative efficacy of VMP vs. Rd in newly diagnosed, autologous stem cell transplant-ineligible multiple myeloma patients: a prematurely terminated randomized controlled study, CAREMM-2002 study

Crossref DOI link: https://doi.org/10.1007/s44313-024-00025-7

Published Online: 2024-07-17

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huh, Cheong Yoon

Park, Sung-Soo

Lee, Jung Yeon

Min, Chang-Ki

Jeon, Young-Woo

Yahng, Seung-Ah

Shin, Seung-Hwan

,
License Information

Text and Data Mining valid from 2024-07-17

Version of Record valid from 2024-07-17
More Information

Article History

Received: 1 March 2024

Accepted: 1 July 2024

First Online: 17 July 2024

Declarations

:

: This study was approved by the institutional review boards of each institution (IRB no. XC20M IDV0001). This study was conducted according to the principles of the Declaration of Helsinki.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below